Genedrive PLC D6M
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if D6M is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- €0.02
- Day Range
- €0.02–0.02
- 52-Week Range
- €0.01–0.25
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €9.23 Mil
- Volume/Avg
- 0 / 16
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.79
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 40
- Website
- http://www.genedriveplc.com
Valuation
|
Metric
|
D6M
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 378.24 |
Price/Sales | 6.79 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
D6M
|
|---|---|
Quick Ratio | 1.36 |
Current Ratio | 1.63 |
Interest Coverage | −247.78 |
Quick Ratio
D6M
Profitability
|
Metric
|
D6M
|
|---|---|
Return on Assets (Normalized) | −98.78% |
Return on Equity (Normalized) | −477.60% |
Return on Invested Capital (Normalized) | −164.96% |
Return on Assets
D6M
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Tclmrpwhq | Lwr | $218.4 Bil | |||
| Danaher Corp
DHR
| Bkbhqcbr | Pnsrzzj | $188.8 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Hkjsffqh | Dkxvr | $41.6 Bil | |||
| IQVIA Holdings Inc
IQV
| Hstpgkw | Yvckhvh | $38.8 Bil | |||
| Agilent Technologies Inc
A
| Qdxbwqmr | Fyzxk | $37.9 Bil | |||
| Mettler-Toledo International Inc
MTD
| Jdhbrkxsn | Rhjnwkh | $31.1 Bil | |||
| Icon PLC
ICLR
| Yrmqdww | Pczhkw | $25.9 Bil | |||
| Waters Corp
WAT
| Mrchnchjcf | Vjss | $17.5 Bil | |||
| Illumina Inc
ILMN
| Qclzjxwm | Vkqstvv | $17.3 Bil | |||
| Labcorp Holdings Inc
LH
| Znshjnns | Cglkbs | $16.8 Bil |